Scaling up the production of a new generation of Iron sources
| Reference number | |
| Coordinator | IRONIC AB |
| Funding from Vinnova | SEK 1 900 000 |
| Project duration | May 2024 - May 2025 |
| Status | Completed |
| Venture | Ground-breaking technology solutions |
| Call | Groundbreaking and scalable technology solutions in 2024 |
Important results from the project
The goal of this project was to establish a robust technology for the scalable production of plant based heme-iron proteins, or IRONIC proteins, within an industrial strain. This objective was successfully met, with IRONIC proteins being synthesized using an industrial strain. As this strain is already approved by regulatory authorities, the pathway for IRONIC proteins to enter the market in both the USA and the EU has been significantly streamlined.
Expected long term effects
The long-term objectives include establishing cost-effective production of IRONIC proteins and streamlined regulatory pathways for the USA and EU. Additionally, prioritizing the use of a commercial strain that is well-recognized by Manufacturing Organizations across various regions is essential. The developed production methodology ensures efficient and cost-effective expansion into diverse markets and regions.
Approach and implementation
The project was executed through a collaborative effort between scientists at IRONIC AB, specializing in plant heme-iron proteins and experts in commercial strain development. Together, we successfully engineered a commercial strain that produces an active molecule with high stability, diverse applications, and excellent iron bioavailability. Additionally, the project facilitated engagement with a manufacturing organization poised to oversee the commercial production of IRONIC proteins.